Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Hisao Higo"'
Autor:
Hiroaki Matsuura, Hisao Higo, Tadahiro Kuribayashi, Akihiko Tamaoki, Takamasa Nakasuka, Mari Uno, Go Makimoto, Kiichiro Ninomiya, Masanori Fujii, Kammei Rai, Eiki Ichihara, Katsuyuki Hotta, Nobuaki Miyahara, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura, Kadoaki Ohashi
Publikováno v:
Thoracic Cancer, Vol 15, Iss 17, Pp 1390-1394 (2024)
Abstract The concurrent incidence of lung cancer and tuberculosis is expected to escalate due to the projected growth in the older population. Combination therapy with osimertinib and antituberculosis drugs has not been well‐established. We report
Externí odkaz:
https://doaj.org/article/d26d7a0f738c4648adc976251c979aaa
Autor:
Masahiro Yamashita, Hisao Higo, Nobuharu Fujii, Chiaki Matsumoto, Go Makimoto, Kiichiro Ninomiya, Masanori Fujii, Kammei Rai, Eiki Ichihara, Kadoaki Ohashi, Katsuyuki Hotta, Masahiro Tabata, Yoshinobu Maeda, Nobuaki Miyahara
Publikováno v:
Respiratory Medicine Case Reports, Vol 51, Iss , Pp 102104- (2024)
A 56-year-old woman who received CD19 chimeric antigen receptor-T cell therapy for refractory diffuse large B-cell lymphoma developed severe coronavirus disease 2019 (COVID-19) and was treated with nirmatrelvir/ritonavir in April 2022. However, she e
Externí odkaz:
https://doaj.org/article/9c01c290090e46b7ac69d6db19592d95
Autor:
Kohei Miyake, Satoru Senoo, Ritsuya Shiiba, Junko Itano, Goro Kimura, Tatsuyuki Kawahara, Tomoki Tamura, Kenichiro Kudo, Tetsuji Kawamura, Yasuharu Nakahara, Hisao Higo, Daisuke Himeji, Nagio Takigawa, Nobuaki Miyahara, Okayama Respiratory Disease Study Group (ORDSG)
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0292507 (2024)
ObjectiveLong-term steroid use increases the risk of developing Pneumocystis pneumonia (PcP), but there are limited reports on the relation of long-term steroid and PcP mortality.MethodsRetrospective multicenter study to identify risk factors for PcP
Externí odkaz:
https://doaj.org/article/1496a60398f248d0940415bb8881f7ba
Autor:
Go Makimoto, Atsushi Shimonishi, Kadoaki Ohashi, Kiichiro Ninomiya, Hisao Higo, Yuka Kato, Masanori Fujii, Toshio Kubo, Eiki Ichihara, Katsuyuki Hotta, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 2, Pp 494-498 (2022)
Tepotinib, the novel MET-tyrosine kinase inhibitor, shows an antitumor effect for patients with non-small-cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation. In January 2022, the AmoyDx® Pan Lung Cancer polymerase chain reaction Panel
Externí odkaz:
https://doaj.org/article/bfc3bf256a774f06afe80a674b5a7557
Autor:
Kayo Nakamura, Etsuko Murakami, Daizo Kishino, Shuko Mashimo, Yusuke Kurioka, Yusaku Shibata, Arihiko Taniguchi, Hisao Higo, Yasushi Hiramatsu, Yoshinobu Maeda, Nobuaki Miyahara
Publikováno v:
Respiratory Medicine Case Reports, Vol 45, Iss , Pp 101894- (2023)
We present the case of a 59-year-old woman diagnosed with Mycobacterium shinjukuense infection using mass spectrometry of bronchioalveolar lavage fluid. We initiated treatment with clarithromycin, rifampicin, and ethambutol based on the results of dr
Externí odkaz:
https://doaj.org/article/cafacb2e7ea34025b97c9507f001db0f
Autor:
Hisao Higo, Kadoaki Ohashi, Shuta Tomida, Sachi Okawa, Hiromasa Yamamoto, Seiichiro Sugimoto, Satoru Senoo, Go Makimoto, Kiichiro Ninomiya, Takamasa Nakasuka, Kazuya Nishii, Akihiko Taniguchi, Toshio Kubo, Eiki Ichihara, Katsuyuki Hotta, Nobuaki Miyahara, Yoshinobu Maeda, Shinichi Toyooka, Katsuyuki Kiura
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Tyrosine kinase activation plays an important role in the progression of pulmonary fibrosis. In this study, we analyzed the expression of 612 kinase-coding and cancer-related genes using next-generation sequencing to identify pote
Externí odkaz:
https://doaj.org/article/0d4105daf2044a01bae3d734d4fb44a5
Autor:
Hisao Higo, Hirohisa Ichikawa, Yukako Arakawa, Yoshihiro Mori, Junko Itano, Akihiko Taniguchi, Satoru Senoo, Goro Kimura, Yasushi Tanimoto, Kohei Miyake, Tomoya Katsuta, Mikio Kataoka, Yoshinobu Maeda, Katsuyuki Kiura, Nobuaki Miyahara, Okayama Respiratory Disease Study Group (ORDSG)
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 16, p 5174 (2023)
Background: Dupilumab is a fully humanized monoclonal antibody that blocks interleukin-4 and interleukin-13 signals. Several large clinical trials have demonstrated the efficacy of dupilumab in patients with severe asthma. However, few studies have e
Externí odkaz:
https://doaj.org/article/bc03c0e20fdf4daf809e58f1d17ec805
Autor:
Masataka Taoka, Go Makimoto, Noriyuki Umakoshi, Kiichiro Ninomiya, Hisao Higo, Yuka Kato, Masanori Fujii, Toshio Kubo, Eiki Ichihara, Kadoaki Ohashi, Katsuyuki Hotta, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Respiratory Medicine Case Reports, Vol 38, Iss , Pp 101669- (2022)
A 76-year-old woman who was treated with lorlatinib for postoperative recurrent anaplastic lymphoma kinase-positive lung adenocarcinoma visited our hospital with massive hemoptysis. Chest computed tomography showed massive bleeding from the right upp
Externí odkaz:
https://doaj.org/article/f8430e62748f401d8a911c8358f80a68
Autor:
Hisao Higo, Takuro Igawa, Katsuhiro Matsuoka, Hiromichi Kawaji, Noriyuki Suzaki, Takuya Nagata, Masako Nagayama, Masaomi Marukawa
Publikováno v:
Respiratory Medicine Case Reports, Vol 33, Iss , Pp 101417- (2021)
The diagnosis of leptomeningeal metastases is sometimes difficult when the cytology of cerebrospinal fluid is negative. We report a rare case of leptomeningeal metastases that required differentiation from paraneoplastic limbic encephalitis. A 67-yea
Externí odkaz:
https://doaj.org/article/18e12eca07a94c9e9282152a87ad8ee9
Autor:
Satoru Senoo, Nobuaki Miyahara, Akihiko Taniguchi, Naohiro Oda, Junko Itano, Hisao Higo, Naofumi Hara, Hiromi Watanabe, Hirohisa Kano, Toshimitsu Suwaki, Yasuko Fuchimoto, Kazuhiro Kajimoto, Hirohisa Ichikawa, Kenichiro Kudo, Takuo Shibayama, Yasushi Tanimoto, Shoichi Kuyama, Arihiko Kanehiro, Yoshinobu Maeda, Katsuyuki Kiura, Okayama Respiratory Disease Study Group (ORDSG)
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0236935 (2020)
BackgroundNintedanib is a multi-kinase inhibitor approved for idiopathic pulmonary fibrosis (IPF); however, its efficacy and safety for patients with IPF and restricted pulmonary function remain unclear. Therefore, the objective of this study was to
Externí odkaz:
https://doaj.org/article/77ed3c530ca741ef9bd6a41697cf6187